Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Manchin To HELP, For Now

Executive Summary

The eventual structure of any user fees that the generic industry may pay could be shaped to some degree by the makeup of the Senate's Health, Education, Labor and Pensions Committee, which would have responsibility for any user fee bills. So the presence of newly-elected Sen. Joe Manchin, D-W.Va., who has joined the panel at least for the rest of the year, is interesting.

You may also be interested in...



Establishment Fees Protect American Manufacturing, Mylan Argues In User Fee Proposal

Mylan President Heather Bresch is drawing attention to the economic implications of not inspecting overseas drug manufacturing facilities as she seeks congressional support for generic user fees to finance such activities.

Establishment Fees Protect American Manufacturing, Mylan Argues In User Fee Proposal

Mylan President Heather Bresch is drawing attention to the economic implications of not inspecting overseas drug manufacturing facilities as she seeks congressional support for generic user fees to finance such activities.

Sen. Byrd's Seat Could Be Filled By More Rx-Focused Successor

West Virginia Gov. Manchin addressed the PhRMA annual meeting in March.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS052962

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel